(Mark One)

[x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended       December 31, 2013

[ ]TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to __________

Commission File Number: 000-54808

NU-MED PLUS, INC.

(Exact name of registrant as specified in charter)

Utah

45-3672530

State or other jurisdiction of

(I.R.S. Employer I.D. No.)

incorporation or organization

455 East 500 South, Suite 205, Salt Lake City, Utah

       84111

 (Address of principal executive offices)                     

  (Zip Code)

Issuer's telephone number, including area code: (801) 746-3570

Securities registered pursuant to section 12(b) of the Act:

Title of each class                 Name of each exchange on which registered

        None                                             N/A  

Securities registered pursuant to section 12(g) of the Act:

Common Stock, $0.001 par value

                             (Title of class)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act

Yes [  ]

No   [X]

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act

Yes [  ]

No   [X]

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

                                                                                                                                                Yes [X]  No [   ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).                                                                                          Yes [X]  No  [  ]

Indicate by check mark if disclosure of delinquent filers in response to Item 405 of Regulation S-K is not contained herein, and not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.    [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large Accelerated filer ¨

Accelerated filer ¨

Non-accelerated filer  ¨ (Do not check if a smaller reporting company)

Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

                                                                                                                                                   Yes [  ]   No [X]

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked prices of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter: The Registrant’s shares do not trade on any market or exchange.

As of February 12, 2014, the Registrant had 31,772,346 shares of common stock issued and outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

List hereunder the following documents if incorporated by reference and the part of the Form 10-K (e.g., part I, part II, etc.) into which the document is incorporated:  (1) Any annual report to security holders; (2) Any proxy or other information statement; and (3) Any prospectus filed pursuant to rule 424(b) or (c) under the Securities Act of 1933: NONE

 EXPLANATORY NOTE

NU-MED PLUS, INC., a Utah corporation (the “Company”) is filing this Amendment No. 1 on Form 10-K/A (this “Amendment”) to amend its Annual Report on Form 10-K for the fiscal year ended December 31, 2013, as filed with the United States Securities and Exchange Commission (the “SEC”) on February 21, 2014 (the “Original Form 10-K”). This Amendment is being filed solely to correct an administrative filing error which resulted in Exhibit 10.2 “Amended Promissory Note” not being filed as well as to correct a typographical error. The Exhibit 10.2 is being filed herewith. In addition, as required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended, new certifications by our principal executive officer and principal financial officer are filed as exhibits hereto.

This Amendment does not amend, modify or otherwise update any other information in the Original Form 10-K and does not reflect events occurring after the filing of the Original Form 10-K. Accordingly, this Amendment should be read in conjunction with the Original Form 10-K, which continues to speak as of the original filing date of the Original Form 10-K.

PART IV

ITEM 15. EXHIBITS, FINANCIAL STATEMNET SCHEDULES

 (a)(3)EXHIBITS.  The following exhibits are included as part of this report:

SEC

Exhibit    

 Reference

Number      

 Number   

Title of Document  

 Location

Item 3      

Articles of Incorporation and Bylaws

 3.01           

3       

Articles of Incorporation

Incorporated

by reference*

 3.02

3

Bylaws

Incorporated

by reference*

Item 4      Instruments Defining the Rights of Security Holders

4.01           

4       

Specimen Stock Certificate

Incorporated

by reference*

10.01

10

Consulting Contract – SCS

Incorporated

By reference**

10.02

10

Amended Promissory Note – SCS

This Filing

31.01

31

CEO certification

This Filing

31.02

31

CFO certification Pursuant

This Filing

32.01           

32

CEO certification

This Filing

32.02           

32

CFO certification

This Filing

101. INS

XBRL Instance

101. XSD 

XBRL Schema

101. CAL

 XBRL Calculation

101. DEF

 XBRL Definition

101. LAB

XBRL Label

101. PRE

XBRL Presentation

*The exhibits were filed with the original Form 10 filed by NU-MED on December 10, 2012, file number 000-54808.

**The consulting contract was filed with the Form 8-K dated January 7, 2014 and filed on January 8, 2014.

SIGNATURES

     Pursuant to the requirements of Section 13 or 15(d) the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

NU-MED PLUS, INC.

March 27, 2014

By:  /s/ Jeffrey L. Robins

Jeffrey L. Robins, CEO, Principal Executive

March 27, 2014

By: /s/ Jeffrey L. Robins

       Jeffrey L. Robins, Principal Accounting Officer

In accordance with Section 12 of the Securities Exchange Act of 1934, the Registrant caused this registration statement to be signed on its behalf by the undersigned in the capacities and on the dates stated.

Signature

Title

Date

/s/ Jeffrey L. Robins

Director, CEO

March 27, 2014

Jeffrey L. Robins

/s/ William G. Moon

Director, Vice President of Operations

March 27, 2014

William G. Moon

/s/ Dr. Craig Morrison

Director, Vice President of Technology

March 27, 2014

Dr. Craig Morrison